Darbepoetin Alfa Treatment of Anemia in Hemodialysis Subjects

Summary

The purpose of this study is to compare once a week and once every other week darbepoetin alfa on the change in hemoglobin levels between the screening/baseline period and the evaluation period (weeks 25-30). This study will also assess the change in mean hemoglobin over 4 week intervals, instability of hemoglobin concentrations, darbepoetin alfa dosing requirements and red blood cell transfusions.

Timeline

Start

2002-08

Primary completion

—

Completion

2003-09

Drugs

Indications